CoChat

Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response

Open access

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Abstract

Gram-negative bacteria actively secrete outer membrane vesicles, spherical nano-meter-sized proteolipids enriched with outer membrane proteins, to the surroundings. Outer membrane vesicles have gained wide interests as non-living complex vaccines or delivery vehicles. However, no study has used outer membrane vesicles in treating cancer thus far. Here we investigate the potential of bacterial outer membrane vesicles as therapeutic agents to treat cancer via immunotherapy. Our results show remarkable capability of bacterial outer membrane vesicles to effectively induce long-term antitumor immune responses that can fully eradicate established tumors without notable adverse effects. Moreover, systematically administered bacterial outer membrane vesicles specifically target and accumulate in the tumor tissue, and subsequently induce the production of antitumor cytokines CXCL10 and interferon-γ. This antitumor effect is interferon-γ dependent, as interferon-γ-deficient mice could not induce such outer membrane vesicle-mediated immune response. Together, our results herein demonstrate the potential of bacterial outer membrane vesicles as effective immunotherapeutic agent that can treat various cancers without apparent adverse effects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-017-00729-8

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Treatment of outer membrane vesicles (OMVs) induces complete regression of tumors. a Transmission electron micrograph image of E. coli W3110 wild type-derived OMVs (WT OMVs) and E. coli W3110 msbB mutant-derived OMVs (∆msbB OMVs). Scale bars, 100 nm. b Size distribution of E. coli W3110 WT and ∆msbB OMVs measured by dynamic light scattering analysis (n = 5). c Production yield of E. coli W3110 WT and ∆msbB OMVs from 1 × 109 CFUs bacteria in terms of total protein amount (n = 5, three independent experiments). d Tumor volume of mice bearing CT26 murine colon adenocarcinoma measured after E. coli ∆msbB OMV treatments with various amounts (total n = 14 mice per group, two independent experiments). E. coli ∆msbB OMVs were injected intravenously four times from day 6 with 3 days intervals. e Picture of tumor and tumor tissue histology 48 h after single PBS or ∆msbB OMV (5 μg in total protein amount) injection. Scale bars, 50 μm. f Picture of mice bearing tumor after PBS or ∆msbB OMV (5 μg in total protein amount) treatments. Yellow box indicates tumor sites. g Mice treated with OMV (5 μg in total protein amount) with complete tumor regression were re-challenged with tumors on the opposite flank of the mice 4 weeks after the final injection. Then, these mice were re-challenged with tumor on the middle of the two flanks of the mice 3 weeks after the secondary tumor injection (total n = 14 mice per group, two independent experiments). Data are presented as the mean ± SD from a representative experiments. ***P < 0.001 analysed by unpaired Student’s t-test c or two-way ANOVA with Bonferroni post test to compare each treated group with PBS group d, g
Fig. 1 Treatment of outer membrane vesicles (OMVs) induces complete regression of tumors. a Transmission electron micrograph image of E. coli W3110 wild type-derived OMVs (WT OMVs) and E. coli W3110 msbB mutant-derived OMVs (∆msbB OMVs). Scale bars, 100 nm. b Size distribution of E. coli W3110 WT and ∆msbB OMVs measured by dynamic light scattering analysis (n = 5). c Production yield of E. coli W3110 WT and ∆msbB OMVs from 1 × 109 CFUs bacteria in terms of total protein amount (n = 5, three independent experiments). d Tumor volume of mice bearing CT26 murine colon adenocarcinoma measured after E. coli ∆msbB OMV treatments with various amounts (total n = 14 mice per group, two independent experiments). E. coli ∆msbB OMVs were injected intravenously four times from day 6 with 3 days intervals. e Picture of tumor and tumor tissue histology 48 h after single PBS or ∆msbB OMV (5 μg in total protein amount) injection. Scale bars, 50 μm. f Picture of mice bearing tumor after PBS or ∆msbB OMV (5 μg in total protein amount) treatments. Yellow box indicates tumor sites. g Mice treated with OMV (5 μg in total protein amount) with complete tumor regression were re-challenged with tumors on the opposite flank of the mice 4 weeks after the final injection. Then, these mice were re-challenged with tumor on the middle of the two flanks of the mice 3 weeks after the secondary tumor injection (total n = 14 mice per group, two independent experiments). Data are presented as the mean ± SD from a representative experiments. ***P < 0.001 analysed by unpaired Student’s t-test c or two-way ANOVA with Bonferroni post test to compare each treated group with PBS group d, gCC BY · PubMed Central
Fig. 2 Systemic administration of bacterial extracellular vesicles induces effective antitumor responses in multiple tumors. a Tumor volume of mice measured after the subcutaneous injection of MC38 murine adenocarcinoma (total n = 14 mice per group, two independent experiments). E. coli ∆msbB OMVs (5 μg in total protein amount) were injected intravenously four times from day 7 with 3 days intervals. b, c To induce spontaneous lung metastasis, highly metastatic 4T1 murine carcinoma cells and B16BL6 melanoma cells were subcutaneously injected to the right flank of the mice (total n = 12 mice per group, two independent experiments). PBS or E. coli ∆msbB OMVs (5 μg in total protein amount) were intravenously treated for four times with 3 days intervals from day 7. At day 22, mice were killed and the number of colonies spontaneously metastasized in the lungs for 4T1 b and B16BL6 c tumors were counted. d, e Tumor volume of mice bearing CT26 tumor of mice intravenously injected with four doses of 5 μg of Gram-negative E. coli W3110 wild type- and Salmonella enterica wild type-derived OMVs. d Gram-positive bacteria Staphylococcus aureus wild type- and lipoteichoic acid (LTA) mutant-derived extracellular vesicles (EVs), and Lactobacillus acidophilus wild type-derived extracellular vesicles (EVs), e (n = 5 mice per group). Data are presented as the mean ± SD from a representative experiments. *P < 0.01 and **P < 0.001, respectively, analysed by unpaired Student’s t-test b, c or two-way ANOVA a, d, e. Bonferroni post test was applied to compare each treated group with PBS group d, e
Fig. 2 Systemic administration of bacterial extracellular vesicles induces effective antitumor responses in multiple tumors. a Tumor volume of mice measured after the subcutaneous injection of MC38 murine adenocarcinoma (total n = 14 mice per group, two independent experiments). E. coli ∆msbB OMVs (5 μg in total protein amount) were injected intravenously four times from day 7 with 3 days intervals. b, c To induce spontaneous lung metastasis, highly metastatic 4T1 murine carcinoma cells and B16BL6 melanoma cells were subcutaneously injected to the right flank of the mice (total n = 12 mice per group, two independent experiments). PBS or E. coli ∆msbB OMVs (5 μg in total protein amount) were intravenously treated for four times with 3 days intervals from day 7. At day 22, mice were killed and the number of colonies spontaneously metastasized in the lungs for 4T1 b and B16BL6 c tumors were counted. d, e Tumor volume of mice bearing CT26 tumor of mice intravenously injected with four doses of 5 μg of Gram-negative E. coli W3110 wild type- and Salmonella enterica wild type-derived OMVs. d Gram-positive bacteria Staphylococcus aureus wild type- and lipoteichoic acid (LTA) mutant-derived extracellular vesicles (EVs), and Lactobacillus acidophilus wild type-derived extracellular vesicles (EVs), e (n = 5 mice per group). Data are presented as the mean ± SD from a representative experiments. *P < 0.01 and **P < 0.001, respectively, analysed by unpaired Student’s t-test b, c or two-way ANOVA a, d, e. Bonferroni post test was applied to compare each treated group with PBS group d, eCC BY · PubMed Central
Fig. 3 Targeting of E. coli ∆msbB OMVs to tumor tissues after systemic administration. a Cy7 control and Cy7-labeled E. coli ∆msbB OMVs (∆msbB Cy7OMVs) were systematically injected to BALB/c mice bearing CT26 tumor cells. For control, ∆msbB Cy7OMVs were also injected to healthy BALB/c mice with no tumor. Whole body distributions of the injected Cy7OMVs were observed using in vivo imaging system spectrum 12 h after the injection. b Spleen, liver, kidney, lung, heart, intestine, and tumor tissues were isolated to measure the accumulation of Cy7 fluorescence in different organs. c Radiant efficiencies of each organ were acquired for Cy7 fluorescence using Living Image 3.1 Software and were normalized by each organ weight. Results are from three independent experiments (total n = 9). d For tumor tissue immunohistochemistry, ∆msbB OMVs were intravenously injected to BALB/c mice bearing CT26 tumor. Tumor tissues were extracted after 12 h and were embedded in paraffin for tissue section analyses by immunohistochemistry. The cell nucleus is stained in blue (Hoechst) and OMVs are shown in red fluorescence signal (anti-E. coli OMV polyclonal antibodies)36 Scale bars, 50 μm. ***P < 0.001 analysed by unpaired Student’s t-test
Fig. 3 Targeting of E. coli ∆msbB OMVs to tumor tissues after systemic administration. a Cy7 control and Cy7-labeled E. coli ∆msbB OMVs (∆msbB Cy7OMVs) were systematically injected to BALB/c mice bearing CT26 tumor cells. For control, ∆msbB Cy7OMVs were also injected to healthy BALB/c mice with no tumor. Whole body distributions of the injected Cy7OMVs were observed using in vivo imaging system spectrum 12 h after the injection. b Spleen, liver, kidney, lung, heart, intestine, and tumor tissues were isolated to measure the accumulation of Cy7 fluorescence in different organs. c Radiant efficiencies of each organ were acquired for Cy7 fluorescence using Living Image 3.1 Software and were normalized by each organ weight. Results are from three independent experiments (total n = 9). d For tumor tissue immunohistochemistry, ∆msbB OMVs were intravenously injected to BALB/c mice bearing CT26 tumor. Tumor tissues were extracted after 12 h and were embedded in paraffin for tissue section analyses by immunohistochemistry. The cell nucleus is stained in blue (Hoechst) and OMVs are shown in red fluorescence signal (anti-E. coli OMV polyclonal antibodies)36 Scale bars, 50 μm. ***P < 0.001 analysed by unpaired Student’s t-testCC BY · PubMed Central
Fig. 4 E. coli ∆msbB OMV antitumor effect is IFN-γ dependent. a, b Release of antitumor cytokines IL-12p40, IFN-γ, and CXCL10 in blood sera a and tumor cell lysate b after single intravenous injection of E. coli ∆msbB OMVs (5 μg in total protein amount) to mice bearing CT26 tumors at different time points. c, d The antitumor efficacy of OMV treatment in CXCL10-deficient (CXCL10−/−) mice c and IFN-γ-deficient (IFN-γ−/−) mice d. Data are shown as the mean ± SD (n = 6 mice per group). NS, not significant, *P < 0.05, **P < 0.01, and ***P < 0.001, respectively, analysed by one-way ANOVA. Bonferroni multiple comparisons post test was applied to compare each time point to zero time point a, b or to compare treated group with PBS group of each mouse c, d
Fig. 4 E. coli ∆msbB OMV antitumor effect is IFN-γ dependent. a, b Release of antitumor cytokines IL-12p40, IFN-γ, and CXCL10 in blood sera a and tumor cell lysate b after single intravenous injection of E. coli ∆msbB OMVs (5 μg in total protein amount) to mice bearing CT26 tumors at different time points. c, d The antitumor efficacy of OMV treatment in CXCL10-deficient (CXCL10−/−) mice c and IFN-γ-deficient (IFN-γ−/−) mice d. Data are shown as the mean ± SD (n = 6 mice per group). NS, not significant, *P < 0.05, **P < 0.01, and ***P < 0.001, respectively, analysed by one-way ANOVA. Bonferroni multiple comparisons post test was applied to compare each time point to zero time point a, b or to compare treated group with PBS group of each mouse c, dCC BY · PubMed Central
Fig. 5 Importance of NK and T cells on OMV antitumor effect. a Images of tumor tissues isolated from wild-type mice bearing CT26 tumors, stained for IFN-γ, and NK cells (top) or T cells (bottom) 48 h after intravenous injections of E. coli ∆msbB OMVs. The cell nucleus is stained in blue (Hoechst), whereas NK and T cells are shown by green fluorescence signal and IFN-γ is shown in red fluorescence signal, respectively. Scale bars, 50 μm. b Images of tumor tissues isolated from wild-type mice bearing CT26 tumors, stained for NK cells (brown spots) at different time points after intravenous injections of E. coli ∆msbB OMVs. Tumor necrotic area around NK cells at 48 h is shown in dashed lines. Scale bars, 50 μm. c, d Tumor volume of NIHS-LystbgFoxn1nuBtkxid mice bearing CT26 tumor measured after E. coli ∆msbB OMV treatments c and tumor weight at the end of the experiment d. Data are presented as the mean ± SD (n = 6 mice per group). NS indicates not significant analysed by two-way ANOVA c and unpaired Student’s t-test d
Fig. 5 Importance of NK and T cells on OMV antitumor effect. a Images of tumor tissues isolated from wild-type mice bearing CT26 tumors, stained for IFN-γ, and NK cells (top) or T cells (bottom) 48 h after intravenous injections of E. coli ∆msbB OMVs. The cell nucleus is stained in blue (Hoechst), whereas NK and T cells are shown by green fluorescence signal and IFN-γ is shown in red fluorescence signal, respectively. Scale bars, 50 μm. b Images of tumor tissues isolated from wild-type mice bearing CT26 tumors, stained for NK cells (brown spots) at different time points after intravenous injections of E. coli ∆msbB OMVs. Tumor necrotic area around NK cells at 48 h is shown in dashed lines. Scale bars, 50 μm. c, d Tumor volume of NIHS-LystbgFoxn1nuBtkxid mice bearing CT26 tumor measured after E. coli ∆msbB OMV treatments c and tumor weight at the end of the experiment d. Data are presented as the mean ± SD (n = 6 mice per group). NS indicates not significant analysed by two-way ANOVA c and unpaired Student’s t-test dCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Cited by

See all 665

Metadata

Authors
Kim, O. Y., Park, H. T., Dinh, N. T. H., Choi, S. J., Lee, J., Kim, J. H., Lee, S.-W., & Gho, Y. S.
Affiliations
Pohang University of Science and Technology (KR)
Corresponding author
  • Kim, Oh Youn
  • Gho, Yong Song
Venue
Nature Communications
Published
2017-09-20
Volume
8
Issue
1
Pages
626-626
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2755907882
Cited by
616
References
44
Citations by year
2026: 68 · 2025: 105 · 2024: 118 · 2023: 108 · 2022: 69 · 2021: 73 · 2020: 41 · 2019: 19 · 2018: 13 · 2017: 1
FWCI
9.14
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Open Access System for Information Sharing (Pohang University of Science and Technology) (submittedVersion)
Funders
  • National Research Foundation
  • Ministry of Science, ICT and Future Planning (CRC-15-02-KRIBB, 2015R1A2A1A10055961)
  • Korea Research Institute of Bioscience and Biotechnology
  • National Research Foundation of Korea (2015R1A2A1A10055961, CRC-15-02-KRIBB)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
bacterial outer membrane vesicles, cancer immunotherapy, interferon-gamma, antitumor immunity, CXCL10, tumor suppression, tumor metastasis prevention, Gram-negative bacteria, tumor-targeted delivery
MeSH terms
Acyltransferases, Adenocarcinoma, Animals, Bacterial Outer Membrane Proteins, Colonic Neoplasms, Escherichia coli, Humans, Immunotherapy, Interferon-gamma, Neoplasm Transplantation, Interleukin-8, Transport Vesicles, Escherichia coli Proteins, Organisms, Genetically Modified, Mice, Chemokine CXCL10, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response. https://app.cochat.ai/papers/10.1038/s41467-017-00729-8
The paper
Kim, O. Y., Park, H. T., Dinh, N. T. H., Choi, S. J., Lee, J., Kim, J. H., Lee, S.-W., & Gho, Y. S. (2017). Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response. Nature Communications. https://doi.org/10.1038/s41467-017-00729-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.